期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Prospects to the formation and control of potential dimer impurity E of pantoprazole sodium sesquihydrate 被引量:4
1
作者 Arun Kumar Awasthi Lalit Kumar +3 位作者 punit tripathi Madhava Golla Cirandur Suresh Reddy Pramod Kumar 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2019年第3期170-177,共8页
Pantoprazole sodium, a substituted benzimidazole derivative, is an irreversible proton pump inhibitor which is primarily used for the treatment of duodenal ulcers, gastric ulcers, and gastroesophageal reflux disease (... Pantoprazole sodium, a substituted benzimidazole derivative, is an irreversible proton pump inhibitor which is primarily used for the treatment of duodenal ulcers, gastric ulcers, and gastroesophageal reflux disease (GERD). The monographs of European Pharmacopoeia (Ph. Eur.) and United States Pharmacopoeia (USP) specify six impurities, viz.;impurities A, B, C, D, E and F, respectively for its active pharmaceutical ingredient (API). The identification and synthesis of all impurities except impurity E are well described in the literature;however, there is no report related to impurity E. The prospects to the formation and controlling of impurity E up to -0.03% in the synthesis of pantoprazole sodium sesquihydrate (PAN) were discussed in detail for the first time. The present work described the journey towards the successful development of an optimal preparation procedure of dimer impurity E. The most plausible mechanism involved in the formation of impurity E has been proposed. 展开更多
关键词 PANTOPRAZOLE sodium sesquihydrate IMPURITY E Oxidation ENRICHMENT COLUMN CHROMATOGRAPHY Characterization HPLC
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部